**NM signifies a non meaningful value. A dash signifies the data is not available.

It is trading on the Nasdaq Global Select Market under the ticker symbol “BIOA ... Market leaders Novo Nordisk (NVO) and Eli Lilly (LLY), the pharmaceutical giants behind popular GLP-1 ...

Denmark’s Novo Nordisk A/S, the obesity drug first mover ... Under Highlights, scroll to click the chart symbol next to Wegovy Tick YOY Growth. Tick Operating Income and YOY Growth for Novo.

The IPO, which should see BioAge start trading on the Nasdaq today under the BIOA symbol, follows a $170 ... and other obesity drugs – including Novo Nordisk's Wegovy (semaglutide) – and ...

Detailed price information for Ishares Global Infrastructure Index ETF (CIF-T) from The Globe and Mail including charting and trades.

The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in ...

Novo Nordisk (NVO) has asked the FDA to ban cheap copies of its weight loss drugs Wegovy and Ozempic, arguing they pose safety risks, ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Oct 21 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Monday an oral version of its drug semaglutide, helped significantly reduce the risk of cardiovascular events in patients in a ...